Skip to content

Insider · CIK 0001369453

Kerry Wentworth

officer

Files at NUVB (Nuvation Bio Inc.). First filing Jun 18, 2025, latest Jun 18, 2025.

Kerry Wentworth files SEC Form 4 as officer at NUVB (Nuvation Bio Inc.). Since Jun 18, 2025, Kerry Wentworth has reported 1 open-market buy worth $90k and 0 open-market sells worth $0, the latest filed on Jun 18, 2025.

A track record needs three past buys with six months of prices behind them; Kerry Wentworth has 0, so none is measured yet.

The newest scored trade: bought $90k of NUVB on Jun 16, 2025, filed Jun 18, 2025, scored 55 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$90k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NUVB: Nuvation Bio Inc.

NUVBOct 9, 2026 · close 5.00

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
55Moderate
NUVBbuy 5
Nuvation Bio Inc.
$90k
50,000 shares
-+12% from low-43% from high

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 27, 2026NUVB
Nuvation Bio Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+748,130$0.00$0748,130Mar 3, 2026
Jun 16, 2025NUVB
Nuvation Bio Inc.
POpen-market purchase
Class A Common Stock
+26,000$1.79$47k26,000Jun 18, 2025
Jun 16, 2025NUVB
Nuvation Bio Inc.
POpen-market purchase
Class A Common Stock
+24,000$1.80$43k50,000Jun 18, 2025

Questions about Kerry Wentworth

Answered from the filings on this page, as of the latest one.

Is Kerry Wentworth buying or selling?

Not in the last 12 months. Kerry Wentworth's latest open-market trade on SEC Form 4 was bought $90k of NUVB on Jun 16, 2025.

How did Kerry Wentworth's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kerry Wentworth has 0.

Where does Kerry Wentworth file Form 4?

Kerry Wentworth has filed Form 4 at NUVB (Nuvation Bio Inc.) as CHIEF REGULATORY OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kerry Wentworth: insider trades and track record | InsiderTell